Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New painkiller cocktail could ease C-Section recovery

NCT ID NCT07072650

Symptom relief Sponsor: Majid Fakhir Mutar Alhamaaidah Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether adding dexmedetomidine to a standard local anesthetic (bupivacaine) in a nerve block after C-section can improve pain relief. 80 women having planned C-sections took part. The goal was to see if the combination extends pain-free time, reduces recovery time, and lowers the need for extra pain medication.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
dexmedetomidine
What this could lead to
If it works, this could provide longer-lasting pain relief after C-sections with less need for additional painkillers.
What could go wrong
This is a small, early-phase trial with only 80 participants. Results may not apply to all patients, and the added drug could cause side effects like sedation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 1

The first testing in people. Mainly checks safety and dose, usually in a small group.

Participants

80 people

The number who actually took part.

Started

Jan 2025

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 40 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age over 18 years' old and less 40 years. * With body mass indices (BMI) between 18.5 and 34.9 kg/m² * Pregnancy more than 37 weeks with single fetus. * Intact membranes. * Women with a singleton pregnancy. Exclusion Criteria: * ASA class III or higher, * contraindications to spinal anesthesia, * mental or neurological disorders, * chronic heart, renal, or liver diseases, * emergency surgery, * a history of blood coagulation disorders, * allergies or contraindications to the study drugs,

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Caesarean section are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Caesarean section Dexmedetomidine Postoperative analgesia Quadratus lumborum block

Contacts and locations

Locations

  • Bint Al-Huda Hospital/ thi qar office directorate

    Nasiriyah, Thi Qar, 64001, Iraq

More trials for these conditions

Other studies related to the condition(s) this trial covers.